Please login to the form below
Aprecia
This page shows the latest Aprecia news and features for those working in and with pharma, biotech and healthcare.
3D printed epilepsy drug launched in the US
Aprecia’s Spritam is now available as a prescription drug. The first ever drug manufactured using 3D printing technology is now available to US patients with epilepsy. ... Aprecia Pharmaceutical's Spritam was approved by the FDA in August last year,
Latest news
-
Printable pharma
Spritam is designed to fill a need for patients who struggle with their current medication experience,” commented Don Wetherhold, Aprecia's chief executive. ... This is the first in a line of central nervous system products Aprecia plans to introduce
-
FDA approves world’s first 3D printed drug
The drug Spritam (levetiracetam), from Aprecia Pharmaceuticals, has been given the green light from the US regulator as an adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and ... experience. "This is the first in a line
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
Featured jobs
- FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...
-
Excellent Daily Rate
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Account Director - Medical Communications - London / South East
-
Excellent Salary and Benefits on offer
-
Account Director – UK Office
-
Excellent salary and benefits
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Account Director, Healthcare Communications
-
Salary TBC
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
Subscribe to our email news alerts
- The relevance of patient perspectives to value
- Sanofi patent case win holds off generic rivals for key cancer drug
- Leo Pharma to market AstraZeneca’s brodalumab outside Europe
- Regeneron scores positive data in phase 3 cholesterol trial
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Putting our core values into practice at the Porterhouse summer social
PMHub
Kendle Healthcare
Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...
Latest intelligence
- The relevance of patient perspectives to value
- Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
- How is the NHS Long-term Plan being put into action?
- Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
- The evolution of real-world studies
- How industry and regulators are using real-world data...
Quick links
Infographics
